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Abstract 
Purpose: To investigate the activity of the aqueous root extract of Salvia miltiorrhiza (S. miltiorrhiza) 
(Lamiaceae), collected from Anhui Province, China, for the treatment of spinal cord injury (SCI) in 
Sprague-Dawley (SD) rats.  
Methods: In total, 30 adult rats were selected and divided into three groups; normal control, untreated 
and treated. Aqueous root extract of S. miltiorrhiza was introduced intraperitoneally to the treated group. 
Basso, Beattie and Bresnahan rating scale (BBB) was used to evaluate improvement in locomotor 
activity after SCI. Total RNA was extracted from tissue sections using Sepasol (NacalaiTesque) and 
RNA samples were reverse-transcribed using M-MLV reverse transcriptase. BioSense SC-810 Gel 
Documentation System and Gel-Pro 3.1 software were employed for the analysis of band intensity. 
Results: A significant reduction in SCI cavity area was observed in the S. miltiorrhiza extract-treated 
group, relative to the untreated group, after 11 days (0.10 ± 0.05 mm2 treated vs. 0.30 ± 0.01 mm2 
untreated). Treatment with root extract also improved the BBB scores; the treated group scored 15, 
compared to a score of 8 for the untreated group. In addition, the degradation of neurons at the site of 
injury in the spinal cord was reduced in the treated group compared to the untreated group. Treatment 
with S. miltiorrhiza aqueous root extract also significantly increased the expression of platelet-derived 
growth factor-B (PDGF-B) mRNA (p < 0.01).  
Conclusion: These data suggest that, in addition to other pharmacological activities, S. miltiorrhiza 
extract has therapeutic potential for the treatment of neuronal degeneration following SCI. 
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Spinal cord injury (SCI), which is primarily 
caused by traffic accidents and falls from high 
altitude, is a frequently encountered global health 
problem [1]. The pathology of SCI can be divided 
into two stages, primary and secondary injury, 
involving (1) compression of spinal cord tissues 
and (2) apoptosis of cells at the site of lesions, 
respectively [2,3]. The permanent loss of 
neurological functions and the associated life-
threatening complications make SCI a major 
clinical issue across the globe [4]. SCI involves 
loss of either partial or complete neuronal 
sensory and motor functions, because of the 
failure of neuronal regeneration. Axonal 
regeneration is inhibited by autonomous cellular 
factors [5,6], astroglial scarring [7,8] and by the 
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accumulation of central nervous system (CNS) 
myelin [8,9]. 
 
There are cells in the CNS that produce platelet-
derived growth factor (PDGF), which has been 
demonstrated to bind to NMDA receptors [10]. It 
is reported that PDGF plays a vital role in 
recovery following CNS injury [10]. The 
mechanism of action of PDGF involves activation 
of tyrosine kinase receptors, including PDGF-αR 
and PDGF-βR. PDGF has also been identified to 
promote the growth of axons and to maintain the 
integrity of neurons [11]. PDGF isoforms induce 
mitosis in glial cells, thereby conferring a 
protective effect on the brain. 
 
Natural products, either in the form of extracts or 
isolated constituents, have been used for the 
treatment of various disorders. Extracts from 
plants like Lycium barbarum (Solanaceae) and S. 
miltiorrhiza root (Lamiaceae) have been shown 
to possess neuroprotective activities [12,13]. It 
has been reported that the alcoholic root and 
rhizome extract of S. miltiorrhiza (Lamiaceae) 
protects the eyes of elderly people and provides 
relief from strain and pain [14,15]. The present 
study was designed to investigate the effect of S. 
miltiorrhiza root extract on rats with SCI. It was 
observed that S. miltiorrhiza (Lamiaceae) root 
extract improved locomotor activity, indicating 







Thirty adult (8 weeks of age) Sprague-Dawley 
(SD) rats were obtained from Guangdong 
Medical Laboratory Animal Co. (Guangdong, 
China). The animals were acclimatized to the 
laboratory atmosphere for 1 week prior to 
commencement of the experiment, and were 
housed under 12 h dark/light cycle conditions 
with free access to water. Experimental 
procedures were carried out according to the 
guidelines approved by the Animal care and use 
committee of Xi'an Jiaotong University (approval 
no. 2014/10C-25).  The studies were carried out 
in accordance with the Directive Office of 
Laboratory Animal Welfare, National Institutes of 
Health (OLAW/NIH 2002) on the guidelines for 
care and safe use of laboratory animals for 




Initially, the plant samples were collected from 
Gunagdong, Sichuan, and Shangdong Provinces 
and all specimens were examined, identified and 
authenticated by Dr. H.W. Wang, Plant 
Taxonomist, China Agricultural University. The 
specimens were registered and the voucher 
specimen (no. HKLPR/IBA/CAS/consult/-2014-
03/438/161) deposited in the Herbarium of the 
Key Laboratory of Plant Resources, Institute of 
Botany, Chinese Academy of Sciences. 
 
S. miltiorrhiza (Lamiaceae) plant root was 
collected, washed with distilled water, dried and 
ground to form a fine powder. The powder was 
added to a mixture of distilled water and 
methanol (1:1 ratio) and macerated for 2 days, 
after which the solvent mixture was evaporated 
and filtered through Whatman paper to obtain a 
pure extract. 
 
Reagents and chemicals 
 
Dimethyl sulphoxide (DMSO) and 3,3'-
diaminobenzidine hydrochloride (DAB) were 
purchased from Sigma Co. (St. Louis, MO, USA). 
Antibodies for PDGF-B and biotinylated goat 
anti-rabbit secondary antibody were obtained 
from Santa Cruz Biotechnology, Inc. (Santa 




The rats were divided randomly into three groups 
(normal control, untreated and treated) of 10 
animals each. The animals in the untreated and 
treated groups were anesthetized by intra 
peritoneal injection of sodium pentobarbital (50 
mg/kg), before exposure of the spinal cord. A 
contusion injury was carefully made in the spinal 
cord of rats in both groups using a weight-drop 
device [17]. The incision was closed by sterile 
suturing and the animals were kept in their 
respective marked cages under sterilized 
conditions.  
 
Animals in the treated group were injected with 
10 µM doses of S. miltiorrhiza root extract every 
other day for 10 days. Animals in the untreated 
and normal control groups were injected with the 
same volume (5 mL/kg) of normal saline. On day 
11, the animals were placed on the floor and 
their locomotor ability was monitored for 10 min 
[18]. Locomotor capacity was scored based on 
the Basso, Beattie and Bresnahan rating scale 
(BBB). 
 
Examination of pathological changes [10] 
 
On day 11, four animals from each group were 
anesthetized and a surgical incision was 
performed to open the thoracic cavity. A segment 
of the thoracic spinal cord from T6 to T14 was 
removed from each animal, washed in normal 
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saline and fixed in 4 % paraformaldehyde in 0.1 
M phosphate-buffered saline (PBS) for 5 h. The 
tissue sections were rinsed twice in PBS and 
then incubated for 45 min with 1 % bovine serum 
albumin (BSA). The sections were then 
incubated with primary antibodies (anti-PDGF-B 
primary antibody) in BSA for 12 h. Following 
incubation, the sections were washed again with 
PBS and incubated with biotinylated goat anti-
rabbit secondary antibody.  
 
The sections were then treated with avidin-horse 
radish peroxidase (HRP) solution. Visualization 
was achieved using DAB and hydrogen peroxide 
dissolved in PBS. The paraffin-embedded 
sections were heated in xylene, and hydrated in 
a gradient of ethyl alcohol. Finally, the sections 
were mounted onto poly-L-lysine-coated slides 
using Permount™. The lesion sites were 
examined under a microscope using H&E 
staining. 
 
Analysis of PDGF-B mRNA expression [18] 
 
Total RNA was extracted from tissue sections 
using Sepasol (NacalaiTesque) according to the 
manufacturer’s protocol. Moloney-murine 
leukemia virus (M-MLV) reverse transcriptase 
(Life Technologies Japan Ltd., Tokyo, Japan) 
was used to reverse-transcribe the RNA 
samples, using a thermal cycler (Takara PCR 
Thermal Cycler S; Takara Bio Inc., Shiga, 
Japan). The mRNA expression levels were 
evaluated using a real-time quantitative RT-PCR 
assay and a Light Cycler System (Roche 
Diagnostics, Mannheim, Germany).  
 
Separation of the PCR products was performed 
using electrophoresis on a 2.0 % agarose gel. A 
BioSense SC-810 Gel Documentation System 
(Shanghai Bio-Tech Co., Ltd., Shanghai, China) 
and Gel-Pro software (ver. 3.1; Media 
Cybernetics, Inc., Bethesda, MD, USA) were 





All of the experiments were performed in 
triplicate and the data are presented as mean ± 
standard deviation (SD). Statistical analysis of 
the data was performed using SPSS for 
Windows software (ver. 16.0; SPSS Inc., 
Chicago, IL, USA).  
 
Statistically significant differences were identified 
using one-way analysis of variance (ANOVA). 





S. miltiorrhiza root extract increased the BBB 
score 
 
The animals belonging to the normal control, 
untreated and treated groups were examined for 
locomotor activity on day 11 post-surgery. It was 
observed that animals in the untreated and 
treated groups suffered from hind limb paralysis 
and were unable to walk normally in the initial 
days after the saline or root extract injection 
regimen was initiated, whereas animals in the 
normal control group walked normally. However, 
treatment with S. miltiorrhiza root extract 
improved recovery from hind limb paralysis; 
animals in the treated group started to walk 
normally after day 10. The BBB score in the S. 
miltiorrhiza root extract-treated group improved, 
reaching 15 points, compared to the 8 points 
scored by the untreated group of rats (Fig 1). 
These findings indicate that S. miltiorrhiza root 
extract has a therapeutic effect on rats following 




Figure 1: Effect of Salvia miltiorrhiza (S. miltiorrhiza) 
root extract on Basso, Beattie and Bresnahan (BBB) 
rating scale scores on days 1 and 11 after surgery. 
The animals in the control and untreated group were 
injected with normal saline, whereas those in the 
treated group were administered 10 µM doses of S. 
miltiorrhiza root extract for 10 days 
 
The results from H&E staining revealed that the 
spinal cord tissues of the untreated group of 
animals featured vacuolar regions, reduced 
numbers of gliocytes and neuronal apoptosis. 
However, treatment of the rats with S. miltiorrhiza 
root extract prevented both the formation of 
vacuoles and neuronal apoptosis. The animals in 
the treatment group were found to possess large 
numbers of gliocytes in the spinal cord at the site 
of injury (Fig. 2). 
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Figure 2: Effect of S. miltiorrhiza root extract on gliocytes in the spinal cord of rats with spinal cord injury. The 
spinal cord tissues were examined under a microscope following H&E staining 
 
S. miltiorrhiza root extract increases the 
expression of PDGF-B 
 
DAB staining revealed that treatment of the 
animals with S. miltiorrhiza root extract induced 
an increase in the proportion of PDGF-B-positive 
cells. Compared to the untreated group, animals 
in the S. miltiorrhiza root extract-treated group 
showed significantly higher numbers of PDGF-B-
positive cells on day 11 after surgery (Fig. 3). S. 
miltiorrhiza root extract also resulted in a 
reduction in the vacuolar region of the spinal cord 
following injury. Analysis of the expression of 
mRNA corresponding to PDGF-B revealed a 
marked increase in the treated group compared 
to the untreated group (Fig. 4). The expression of 
mRNA corresponding to PDGF-B in the treated 





Figure 3: Treatment with S. miltiorrhiza root extract 
increased the proportion of PDGF-B-positive cells in 




Figure 4: Effect of S. miltiorrhiza root extract on the 
expression of platelet-derived growth factor-B (PDGF-




Extracts of plants such as Lycium barbarum and 
S. miltiorrhiza have been shown to possess 
promising neuroprotective activities [12,13]. In 
the present study, S. miltiorrhiza root extract was 
shown to be beneficial for the treatment of rats 
with SCI. S. miltiorrhiza root extract induced a 
significant improvement in recovery compared to 
untreated rats. Rats in the treatment group 
showed significantly higher BBB scores and 
reduced neuronal apoptosis 11 days after 
surgery. Axons were also found to show 
regeneration in animals treated with S. 
miltiorrhiza root extract. 
 
The PDGF, which has been demonstrated to 
bind to NMDA receptors, is secreted by cells in 
the CNS [10]. It is reported that PDGF plays a 
vital role in recovery following CNS injury [10]. 
The mechanism of action of PDGF involves 
activation of tyrosine kinase receptors, including 
PDGF-αR and PDGF-βR. PDGF has also been 
shown to promote the growth of axons and to 
maintain the integrity of neurons [11]. PDGF 
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isoforms induce mitosis in glial cells, thereby 
affecting a protective effect on the brain. 
 
It is reported that PDGF protects dopaminergic 
neurons from toxicity induced by Tat proteins. 
Increasing PDGF expression may therefore be a 
promising therapeutic strategy for SCI. The 
results from the present study revealed that S. 
miltiorrhiza root extract enhances the expression 
of PDGF-B 10 days after surgery. The 
improvement in recovery of rats treated with S. 
miltiorrhiza root extract following SCI may 
therefore be associated with promotion of PDGF-
B expression. Reports indicate that the 
proportion of PDGF-positive cells in the spinal 
cord of rats is significantly higher following SCI 
[17,21]. PDGF-B plays an important role in the 
protection of neurons by inhibiting glutamate 
transporters in the cell membrane. Furthermore, 
enhancement of the PDGF-B/receptor signal 
pathway may rescue neonatal brains at risk of 
hypoxic-ischemic injury [22]. 
 
Thus, we conclude that the root extract of S. 
miltiorrhiza has the capacity to improve recovery 
from SCI in rats, via a mechanism involving 
promotion of PDGF-B expression. Therefore, 
Salvia miltiorrhiza extract may be of potential 




The findings of the present study demonstrate 
that the root extract of S. miltiorrhiza significantly 
improves recovery, as indicated by increase in 
locomotor activity, following SCI injury in a rat 
model. The results also suggest that S. 
miltiorrhiza root extract has therapeutic potentials 
for the treatment of neuronal degeneration 
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